Replies to post #1864 on Momenta Pharmaceuticals, Inc. (MNTA)

[Mpower]

:)

mL (sole generic) approval did nothing for the stock... why should we expect mC approval to be any different. Sure there are some nuances affecting post-mL approval pricing -- royalty structure, TEVA's threats, etc... but mC approval is no more of a "goldmine" than mL was touted to be. (some new overhang will come up). The only hope we have is a acquisition of MNTA.

P.S. The weather in Tripoli, Wisconsin and Tripoli, Iowa are less than ideal. The weather in Tripoli, Libya is a beautiful 75 degrees Fahrenheit, with a slight chance of revolution. :P